ResMed Profits Soar in the US Market After Dodging Trump Tariffs
Key Points: ResMed achieved a 9% revenue increase in the Americas after securing an exemption from trade tariffs. The $43 billion Australian medical company bypassed the 10% levy thanks to the international Nairobi Protocol treaty. Chief Executive Officer Mick Farrell...